|
Volumn 6, Issue 2, 1996, Pages 59-63
|
Paclitaxel dose intensity.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PACLITAXEL;
BREAST TUMOR;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
OVARY TUMOR;
PHASE 3 CLINICAL TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
EID: 0030090472
PISSN: 10600051
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (33)
|